• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦开伯尔-普赫图赫瓦省十大医院报告的 COVID-19 患者的临床特征、死亡率及相关危险因素。

Clinical Characteristics, Mortality and Associated risk factors in COVID-19 patients reported in ten major hospitals of Khyber Pakhtunkhwa, Pakistan.

机构信息

Khyber Medical University, Peshawar & Institute of Health and Wellbeing, University of Glasgow, UK.

Khyber Medical University, Peshawar.

出版信息

J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(Suppl 1)(4):S633-S639.

PMID:33754522
Abstract

BACKGROUND

COVID-19 is an ongoing public health issue across the world. Several risk factors associated with mortality in COVID-19 have been reported. The present study aims to describe clinical and epidemiological characteristics and predictors of mortality in hospitalized patients from Khyber Pakhtunkhwa, a province in Pakistan with highest COVID-19 associated case fatality rate.

METHODS

This multicentre, retrospective study was conducted in hospitalized COVID-19 patients who died or discharged alive until 1st May 2020. Data about sociodemographic characteristics, clinical and laboratory findings, treatment and outcome were obtained from hospital records and compared between survivors and non-survivors. Statistical tests were applied to determine the risk factors associated with mortality in hospitalized patients.

RESULTS

Of the total 179 patients from the 10 designated hospitals, 127 (70.9%) were discharged alive while 52 (29.1%) died in the hospital. Overall, 109 (60.9%) patients had an underlying comorbidity with hypertension being the commonest. Multivariate logistics regression analysis showed significantly higher odds of in-hospital death from COVID-19 in patients with multiple morbidities (OR 3.2, 95% CI 1.1, 9.1, p-value=0.03), length of hospital stay (OR 0.8, 95% CI 0.7, 0.9, p-value <0.001), those presenting with dyspnoea (OR 4.0, 95% CI 1.1, 14.0, p-value=0.03) and oxygen saturation below 90 (OR 9.6, 95% CI: 3.1, 29.2, p-value <0.001).

CONCLUSION

Comorbidity, oxygen saturation and dyspnoea on arrival and length of stay in hospital (late admission) are associated with COVID-19 mortality. The demographic, clinical and lab characteristics could potentially help clinician and policy makers before potential second wave in the country.

摘要

背景

COVID-19 是全球范围内持续存在的公共卫生问题。已经报道了与 COVID-19 死亡率相关的几个危险因素。本研究旨在描述巴基斯坦开伯尔-普赫图赫瓦省住院患者的临床和流行病学特征以及死亡的预测因素,该省 COVID-19 相关病死率最高。

方法

这是一项多中心、回顾性研究,对象为截至 2020 年 5 月 1 日死亡或出院的住院 COVID-19 患者。从医院记录中获取有关社会人口统计学特征、临床和实验室检查结果、治疗和结局的数据,并在存活者和非存活者之间进行比较。应用统计学检验确定与住院患者死亡相关的危险因素。

结果

在来自 10 家指定医院的 179 名患者中,127 名(70.9%)出院存活,52 名(29.1%)在医院死亡。总体而言,109 名(60.9%)患者有合并症,其中最常见的是高血压。多变量逻辑回归分析显示,患有多种合并症的 COVID-19 患者住院死亡的可能性显著增加(OR 3.2,95%CI 1.1,9.1,p 值=0.03)、住院时间(OR 0.8,95%CI 0.7,0.9,p 值<0.001)、呼吸困难(OR 4.0,95%CI 1.1,14.0,p 值=0.03)和血氧饱和度低于 90%(OR 9.6,95%CI:3.1,29.2,p 值<0.001)。

结论

合并症、入院时的血氧饱和度和呼吸困难以及住院时间(入院较晚)与 COVID-19 死亡率相关。这些人口统计学、临床和实验室特征可能有助于临床医生和决策者在该国可能出现第二波疫情之前做出决策。

相似文献

1
Clinical Characteristics, Mortality and Associated risk factors in COVID-19 patients reported in ten major hospitals of Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省十大医院报告的 COVID-19 患者的临床特征、死亡率及相关危险因素。
J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(Suppl 1)(4):S633-S639.
2
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
3
Isaric 4c Mortality Score As A Predictor Of In-Hospital Mortality In Covid-19 Patients Admitted In Ayub Teaching Hospital During First Wave Of The Pandemic.伊萨里克4c死亡率评分作为第一波疫情期间阿尤布教学医院收治的新冠肺炎患者院内死亡率的预测指标。
J Ayub Med Coll Abbottabad. 2021 Jan-Mar;33(1):20-25.
4
The impact of hospital saturation on non-COVID-19 hospital mortality during the pandemic in France: a national population-based cohort study.医院饱和对法国大流行期间非 COVID-19 医院死亡率的影响:一项全国基于人群的队列研究。
BMC Public Health. 2024 Jul 5;24(1):1798. doi: 10.1186/s12889-024-19282-3.
5
Cases of acute coronary syndrome and presumed cardiac death prior to arrival at an urban tertiary care hospital in Pakistan during the COVID-19 pandemic.在巴基斯坦 COVID-19 大流行期间,到达城市三级护理医院之前出现急性冠状动脉综合征和疑似心源性死亡的病例。
PLoS One. 2022 Feb 3;17(2):e0263607. doi: 10.1371/journal.pone.0263607. eCollection 2022.
6
Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru.秘鲁利马一家公立医院住院的 COVID-19 成年患者的氧饱和度与死亡率的关系。
PLoS One. 2020 Dec 28;15(12):e0244171. doi: 10.1371/journal.pone.0244171. eCollection 2020.
7
Impact of age, sex, race, and regionality on major clinical outcomes of COVID-19 in hospitalized patients in the United States.年龄、性别、种族和地域对美国住院 COVID-19 患者主要临床结局的影响。
BMC Infect Dis. 2022 Jul 29;22(1):659. doi: 10.1186/s12879-022-07611-z.
8
Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: a retrospective cohort study.伊朗戈勒斯坦省 COVID-19 疫情的流行病学和临床特征及与死亡率相关的因素:一项回顾性队列研究。
J Prev Med Hyg. 2021 Jul 30;62(2):E298-E304. doi: 10.15167/2421-4248/jpmh2021.62.2.1910. eCollection 2021 Jun.
9
Risk factors for mortality in hospitalized COVID-19 patients across five waves in Pakistan.巴基斯坦 COVID-19 患者住院期间五个波次的死亡风险因素。
Sci Rep. 2024 Aug 30;14(1):20205. doi: 10.1038/s41598-024-70662-6.
10
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.

引用本文的文献

1
Impact of Comorbidity on the Duration from Symptom Onset to Death in Patients with Coronavirus Disease 2019: A Retrospective Study of 104,753 Cases in Pakistan.合并症对2019冠状病毒病患者从症状出现到死亡持续时间的影响:巴基斯坦104753例病例的回顾性研究
Diseases. 2023 Dec 1;11(4):176. doi: 10.3390/diseases11040176.
2
Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan.两剂疫苗接种显著延长了从症状出现到死亡的时间:基于巴基斯坦开伯尔-普赫图赫瓦省 173894 例 SARS-CoV-2 病例的回顾性研究。
Int J Environ Res Public Health. 2022 Sep 13;19(18):11531. doi: 10.3390/ijerph191811531.
3
Hospital length of stay for COVID-19 patients: a systematic review and meta-analysis.
新冠病毒肺炎患者的住院时长:一项系统评价与荟萃分析
Multidiscip Respir Med. 2022 Aug 9;17(1):856. doi: 10.4081/mrm.2022.856. eCollection 2022 Jan 12.
4
Seroprevalence of Sars-Cov-2 antibodies among eligible blood donors of Peshawar, Pakistan.巴基斯坦白沙瓦符合条件的献血者中新冠病毒2型抗体的血清流行率。
Am J Blood Res. 2022 Jun 20;12(3):88-96. eCollection 2022.
5
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.